v3.26.1
Award Timing Disclosure
 12 Months Ended
Dec. 31, 2025
Feb. 25, 2025
USD ($)
shares
$ / shares
Feb. 24, 2025
USD ($)
shares
$ / shares
Award Timing Disclosures [Line Items]      
Award Timing MNPI Disclosure
Practices Related to the Grant of Certain Equity Awards
The Company generally maintains a structured equity grant timing process designed to ensure compliance with applicable securities laws, corporate governance best practices, and the avoidance of material nonpublic information (“MNPI”) in granting equity awards. The Compensation Committee generally grants annual equity-based awards to our executive officers in February of each year, in connection with our annual compensation review and approval process, although the exact timing may change from year to year. Our Compensation Committee may also grant equity awards, including RSUs and stock options, at different times of the year for new hires and in connection with promotions, or grants made for retention or other purposes.
Stock option
exercise
prices are set at the closing price of the Company’s common stock on the grant date, in accordance with the Company’s equity plan and applicable securities regulations. This process is designed to prevent any appearance of opportunistic grant timing and to ensure that equity awards are made in a manner that reflects long-term stockholder value creation. Our Compensation Committee does not grant equity awards in anticipation of the release of MNPI and we have not timed the disclosure of MNPI for the purpose of affecting the value of executive compensation.
 
During 2025, the Company granted the following stock options to named executive officers during a period beginning four business days before and ending one business day after the filing of any Company periodic report on Form
10-Q
or Form
10-K,
or the filing or furnishing of any Company current report on Form
8-K
(other than a current report on Form
8-K
disclosing a material new option award grant under Item 5.02(e) of that form) that disclosed any MNPI:
 
Name
   
Grant date
   
Number of
securities
underlying
the award
   
Exercise
price of
the award
($/Sh)
   
Grant date
fair value
of the award
   
Percentage change in the
closing market price of the
securities underlying the
award between the trading
day ending immediately
prior to the disclosure of
material nonpublic
information and the trading
day beginning immediately
following the disclosure of
material nonpublic
information
Waleed H. Hassanein, M.D.
        2/25/2025        90,185      $ 73.00      $ 4,360,147        3.47%  
Gerardo Hernandez
        2/24/2025        5,299      $ 77.12      $ 271,120        3.47%  
Tamer Khayal, M.D.
        2/24/2025        26,499      $ 77.12      $ 1,355,805        3.47%  
Nicholas Corcoran
        2/24/2025        19,079      $ 77.12      $ 976,166        3.47%  
Anil Ranganath
        2/24/2025        8,479      $ 77.12      $ 433,823        3.47%  
    
MNPI Disclosure Timed for Compensation Value false    
Awards Close in Time to MNPI Disclosures, Table
Name
   
Grant date
   
Number of
securities
underlying
the award
   
Exercise
price of
the award
($/Sh)
   
Grant date
fair value
of the award
   
Percentage change in the
closing market price of the
securities underlying the
award between the trading
day ending immediately
prior to the disclosure of
material nonpublic
information and the trading
day beginning immediately
following the disclosure of
material nonpublic
information
Waleed H. Hassanein, M.D.
        2/25/2025        90,185      $ 73.00      $ 4,360,147        3.47%  
Gerardo Hernandez
        2/24/2025        5,299      $ 77.12      $ 271,120        3.47%  
Tamer Khayal, M.D.
        2/24/2025        26,499      $ 77.12      $ 1,355,805        3.47%  
Nicholas Corcoran
        2/24/2025        19,079      $ 77.12      $ 976,166        3.47%  
Anil Ranganath
        2/24/2025        8,479      $ 77.12      $ 433,823        3.47%  
    
Waleed H. Hassanein, M.D. [Member]      
Awards Close in Time to MNPI Disclosures      
Name   Waleed H. Hassanein, M.D.  
Underlying Securities | shares   90,185  
Exercise Price | $ / shares   $ 73  
Fair Value as of Grant Date | $   $ 4,360,147  
Underlying Security Market Price Change   3.47  
Nicholas Corcoran [Member]      
Awards Close in Time to MNPI Disclosures      
Name     Nicholas Corcoran
Underlying Securities | shares     19,079
Exercise Price | $ / shares     $ 77.12
Fair Value as of Grant Date | $     $ 976,166
Tamer Khayal, M.D. [Member]      
Awards Close in Time to MNPI Disclosures      
Name     Tamer Khayal, M.D.
Underlying Securities | shares     26,499
Exercise Price | $ / shares     $ 77.12
Fair Value as of Grant Date | $     $ 1,355,805
Underlying Security Market Price Change     3.47
Gerardo Hernandez [Member]      
Awards Close in Time to MNPI Disclosures      
Name     Gerardo Hernandez
Underlying Securities | shares     5,299
Exercise Price | $ / shares     $ 77.12
Fair Value as of Grant Date | $     $ 271,120
Underlying Security Market Price Change     3.47
Anil Ranganath [Member]      
Awards Close in Time to MNPI Disclosures      
Name     Anil Ranganath
Underlying Securities | shares     8,479
Exercise Price | $ / shares     $ 77.12
Fair Value as of Grant Date | $     $ 433,823
Underlying Security Market Price Change     3.47